- Home
- ORC vs AUTL Comparison
ORC vs AUTL Comparison
Compare ORC & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORC
- AUTL
- Stock Information
- Founded
- ORC 2010
- AUTL 2014
- Country
- ORC United States
- AUTL United Kingdom
- Employees
- ORC N/A
- AUTL N/A
- Industry
- ORC Real Estate Investment Trusts
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ORC Real Estate
- AUTL Health Care
- Exchange
- ORC Nasdaq
- AUTL Nasdaq
- Market Cap
- ORC 660.1M
- AUTL 625.4M
- IPO Year
- ORC 2013
- AUTL 2018
- Fundamental
- Price
- ORC $6.98
- AUTL $2.25
- Analyst Decision
- ORC Hold
- AUTL Strong Buy
- Analyst Count
- ORC 3
- AUTL 5
- Target Price
- ORC N/A
- AUTL $9.32
- AVG Volume (30 Days)
- ORC 3.7M
- AUTL 2.5M
- Earning Date
- ORC 07-24-2025
- AUTL 08-07-2025
- Dividend Yield
- ORC 20.54%
- AUTL N/A
- EPS Growth
- ORC N/A
- AUTL N/A
- EPS
- ORC 0.46
- AUTL N/A
- Revenue
- ORC $52,240,000.00
- AUTL $9,011,000.00
- Revenue This Year
- ORC $46.17
- AUTL $461.76
- Revenue Next Year
- ORC $26.45
- AUTL $112.66
- P/E Ratio
- ORC $15.29
- AUTL N/A
- Revenue Growth
- ORC N/A
- AUTL N/A
- 52 Week Low
- ORC $5.69
- AUTL $1.11
- 52 Week High
- ORC $9.01
- AUTL $5.00
- Technical
- Relative Strength Index (RSI)
- ORC 53.58
- AUTL 69.32
- Support Level
- ORC $7.00
- AUTL $1.98
- Resistance Level
- ORC $7.09
- AUTL $2.10
- Average True Range (ATR)
- ORC 0.11
- AUTL 0.13
- MACD
- ORC 0.01
- AUTL -0.00
- Stochastic Oscillator
- ORC 77.94
- AUTL 73.63
About ORC Orchid Island Capital Inc.
Orchid Island Capital Inc is a specialty finance company that invests in residential mortgage-backed securities. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.